Robert L. Redner

4.2k citations
77 papers · 3.5k · 1 hit paper · h-index 21

Impact in

  • Hematology top 0.5%
    • Platelet Disorders and Treatments
    • Acute Myeloid Leukemia Research
    • Retinoids in leukemia and cellular processes
    • Genomics and Chromatin Dynamics
    • Histone Deacetylase Inhibitors Research
    • RNA Interference and Gene Delivery
    • DNA and Nucleic Acid Chemistry

Papers in

    • Acute Myeloid Leukemia Research 32
    • Platelet Disorders and Treatments 6
    • Multiple Myeloma Research and Treatments 5
    • Chronic Myeloid Leukemia Treatments 3
    • Retinoids in leukemia and cellular processes 23
    • RNA Research and Splicing 3
    • DNA and Nucleic Acid Chemistry 3
    • RNA Interference and Gene Delivery 2

Robert L. Redner

74 papers receiving 3.3k citations

Robert L. Redner's Hit Papers

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial 2008 · 712 citations
7120+6+12Years since publication200400600

Peers

Robert L. Redner
Comparison fields: 5 of 90
  • Hematology 1.6k
  • Molecular Biology 1.3k
  • Oncology 312
  • Immunology 192
  • Pharmacology 69
Replace Tetsuzo Tauchi with:
Tetsuzo Tauchi Japan
Astrid Gruber Sweden
Robert L Ilaria United States
Mohammed Amen Wattad Germany
Fumio Bessho Japan
Ulrike Heider Germany
Yongmei Zhu China
Daniel Steinbach Germany
Antonella Gozzini Italy
Susanne F. Viehmann Germany
Robert L. Redner relative to Tetsuzo Tauchi Japan Tetsuzo Tauchi's profile →
Citations per field
00.5×1.5×2×2.4×
Tetsuzo Tauchi · 1×
Citations per year

Countries citing papers authored by Robert L. Redner

Since Specialization
Citations

This map shows the geographic impact of Robert L. Redner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Redner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Redner more than expected).

Fields of papers citing papers by Robert L. Redner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Redner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Redner. The network helps show where Robert L. Redner may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert L. Redner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert L. Redner Line = papers co-authored together Robert L. Redner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
Hit paper breakdown →
2008712
2 1998450
3 1988432
4
Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells.
1999175
5 1999166
6 2017157
7 1990135
8 2008122
9 1992103
10 199993
11 201082
12 200955
13 200554
14
A non-classical translocation involving 17q12 (retinoic acid receptor alpha) in acute promyelocytic leukemia (APML) with atypical features.
199453
15 200053
16 199751
17 201548
18 200843
19 200941
20 201431

About Robert L. Redner

Robert L. Redner is a scholar working on Hematology, Molecular Biology, Oncology, Immunology and Pharmacology, having authored 77 papers that have together received 3.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (32 papers), Retinoids in leukemia and cellular processes (23 papers), Platelet Disorders and Treatments (6 papers), Multiple Myeloma Research and Treatments (5 papers), RNA Research and Splicing (3 papers), DNA and Nucleic Acid Chemistry (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Hematology (1.6k citations), Molecular Biology (1.3k citations), Oncology (312 citations), Immunology (192 citations) and Pharmacology (69 citations). Robert L. Redner has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include Johnson M Liu, Jianxiang Wang, Arthur W. Nienhuis, Jeffrey T. Holt, Taizo Hoshino, Sachiko Kajigaya, Daniel E. Johnson, Yogen Saunthararajah, Kathleen Anne Dorritie and Michael P. Cooke. Their work appears in journals such as Blood, Leukemia Research, Leukemia, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact